Navigation Links
Transcept Pharmaceuticals to Present at 19th Annual Piper Jaffray Health Care Conference
Date:11/14/2007

PT. RICHMOND, Calif., Nov. 14 /PRNewswire/ -- Transcept Pharmaceuticals, Inc. today announced that Thomas P. Soloway, Senior Vice President and Chief Financial Officer, will present at the 19th Annual Piper Jaffray Health Care Conference at the Pierre Hotel in New York City on Tuesday, November 27, 2007 at 10:30 AM Eastern Time.

About Transcept Pharmaceuticals

Transcept Pharmaceuticals, Inc. is a specialty pharmaceutical company deriving significant new patient benefits from proven CNS drugs. Transcept development projects leverage new understanding of CNS conditions to provide additional uses and enhanced clinical benefits for existing active agents. The lead Transcept product, Intermezzo(R) (zolpidem tartrate lozenge), is a low dose sublingual formulation of zolpidem that is currently in late phase 3 clinical trials for the treatment of insomnia in patients who awaken in the middle of the night and have difficulty returning to sleep. Another product being developed by Transcept is TO-2060, a novel, fixed-dose combination of olanzapine and ondansetron for the treatment of dopamine associated psychiatric disorders. TO-2060 is currently the subject of an initial proof of concept trial in the treatment of alcohol use disorder. For more information, please visit the company's website at: http://www.transcept.com.

Contacts:

Transcept Pharmaceuticals, Inc. The Ruth Group

Michael Gill, Investors / Media

Director of Communications Stephanie Carrington / Jason Rando

(510) 215-3575 (646) 536-7017 / 7025

mgill@transcept.com scarrington@theruthgroup.com

jrando@theruthgroup.com


'/>"/>
SOURCE Transcept Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
2. Transcept Pharmaceuticals, Inc. to Present at 2007 BIO Investor Forum
3. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
4. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
5. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
6. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
7. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
8. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
9. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
10. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
11. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2008)...ices for Frail Seniors and People With,Disabilitie.../ -- Thousands of,homecare workers across the stat...posed cuts to hours of service, wages and benefits...erable workers and the,people they serve deeper in...ces for seniors and people with disabilities from ...
(Date:5/16/2008)... more unemployed politicians - and economists, O...hough nearly all,voters place health care at the t...g federal budgetary crunch means none of the healt...ential candidates is likely to become,law anytime ... Frist., Jousting with Princeton University Healt...
(Date:5/16/2008)...ese students learn the lesson of helping others ...e, NANJING, China, May 16 /PRNewswire/ -- In the ...ven the youngest members of China are,looking for ...ll around the,country, schools are running donatio...hool,s principal, Ms. Zhang Lijun, the 190-student...
(Date:5/16/2008)...swire-FirstCall/ -- CryoCor, Inc. (Nasdaq:,CRYO), ...of cardiac,arrhythmias, announced today that on Ma...tock filed a complaint in the Superior Court of th... as defendants each member of the,Board of Directo...ration.,The complaint is styled Secondido, et al. ...
Breaking Medicine News(10 mins):Health News:Homecare Workers Outraged by Proposed Cuts, Wage Reductions 2Health News:Former Senate Majority Leader, Princeton Economist Joust on Future of Health Care 2Health News:Former Senate Majority Leader, Princeton Economist Joust on Future of Health Care 3Health News:Chinese Preschoolers Participate in Fund Drive to Help the Victims of Sichuan Quake 2Health News:CryoCor, Inc. Subject of Lawsuit Relating to Tender Offer and Merger 2Health News:CryoCor, Inc. Subject of Lawsuit Relating to Tender Offer and Merger 3Health News:CryoCor, Inc. Subject of Lawsuit Relating to Tender Offer and Merger 4
...rs at a computer can harm your eyes, say experts, ...r so to minimise the damage. Studies have shown...r in as many as nine out of 10 people using video ... Beebe, an optometrist and spokesman for the Ameri...
... farm milk can protect children against asthma and...hildren published in the May issue of Clinical an...hat hasnt been boiled poses serious health risks a...elop a safe product that still provides good prote...
...ers at the University of Illinois at Chicago, in c...Upjohn and Pfizer, have discovered precisely how .... Scientists have known that the drug linezolid -...the marketplace in 30 years -- works by binding to...
...ral government is aiming for 100 percent registrat... of Birth and Death Act 1969 that would simplify ...on at birth is a serious issue as this helps in ma...his or her lifetime. In India, currently the birth...
Other Medicine News:Health News:Many Hours on Computer may Harm Eyes 2Health News:Farm Milk Reduces Childhood Asthma and Allergies but Raw Consumption is Unsafe 2Health News:Researchers Discover How Antibiotic Inhibits Bacterial Growth 2Health News:Government to Amend Birth Registration Act 2
(Date:5/16/2008)...bles First-Ever PEGylation of a Small Molecule wit...ity, SAN CARLOS, Calif., May 16 /PRNewswire-First...unced initial results today from a Phase 1,study o...significant,anti-tumor activity in patients with r...s that Nektar,s small molecule PEGylation technolo...
(Date:5/16/2008)... Statistically Significant Reductions in Selected ...stract to be published in 2008 Proceedings of the ...ical Oncology, SAN DIEGO, May 16 /PRNewswire-Firs...NX ) announced today that, in a registrational bio... statistically significant reduction,in general di...
(Date:5/15/2008)...5 /- Medivation, Inc.,(Nasd...ing Phase 1-2 clinical,trial of its novel androgen...n an oral presentation at the 44th American Societ...icago., Session title: New Targeted Strategies ...d time: Monday, June 2 at 11:30 a.m. Central Time ...
(Date:5/15/2008)..., May 15 /- Cytopia Limited...its upcoming oral,presentation on CYT997 at the 20...cal Oncology (ASCO) will be accessible to the publ... 9pm on Thursday 15 May (US EDT)., The oral prese... novel,cytotoxic and vascular disrupting agent, in...
Breaking Medicine Technology:Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings 2Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings 3Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings 4Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings 5ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study 2ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study 3ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study 4ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study 5Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting 2Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting 3iJET Unveils 2007 Year in Review Report on Avian Influenza and Pandemic Planning 11617 1iJET Unveils 2007 Year in Review Report on Avian Influenza and Pandemic Planning 11617 2iJET Unveils 2007 Year in Review Report on Avian Influenza and Pandemic Planning 11617 3AMN Healthcare Appoints Hala Moddelmog to Its Board of Directors 11614 1AMN Healthcare Appoints Hala Moddelmog to Its Board of Directors 11614 2AMN Healthcare Appoints Hala Moddelmog to Its Board of Directors 11614 3New Survey Shows African Americans Are Concerned With Heart Health but Unaware of Link to Brain Health 11612 1New Survey Shows African Americans Are Concerned With Heart Health but Unaware of Link to Brain Health 11612 2New Survey Shows African Americans Are Concerned With Heart Health but Unaware of Link to Brain Health 11612 3New Survey Shows African Americans Are Concerned With Heart Health but Unaware of Link to Brain Health 11612 4Latest Salvo Fired in Frozen Yogurt Wars as Southern Californias Fastest Growing Franchise Cefiore Launches New Chocolate Flavor 11609 1Latest Salvo Fired in Frozen Yogurt Wars as Southern Californias Fastest Growing Franchise Cefiore Launches New Chocolate Flavor 11609 2
...S, N.J.--(BUSINESS WIRE)--Mar 19, 2007 - Nymox,Pha...nced positive,results from its newly completed lon...ic hyperplasia (BPH). 26 clinical trial sites,acro...ed in the,blinded, placebo controlled study., The ...e 8-19,months after NX-1207 treatment. Overall, wi...
...sults,to Be Presented at the American College of C...19/2007 -- AtheroGenics, Inc. (NASDAQ: AGIX) today... of its lead drug,candidate, AGI-1067, did not sho...ry endpoint; however, it did achieve a number of,o...ts included a,reduction in the composite of "hard"...
Other Medicine Technology:Nymox Announces Positive Results from Newly Completed Long-term,Study of NX-1207 for Benign Prostatic Hyperplasia 2Nymox Announces Positive Results from Newly Completed Long-term,Study of NX-1207 for Benign Prostatic Hyperplasia 3AtheroGenics Reports ARISE Trial Results for AGI-1067 2AtheroGenics Reports ARISE Trial Results for AGI-1067 3AtheroGenics Reports ARISE Trial Results for AGI-1067 4
Designed as an excellent form of primary suspension
...enefits of controlled compression and cold, the Ca... pain. The anatomically designed cuff provides com...yo/Cuffs can be ordered as a single cuff, or with ... disk). The Cooler is available separately and can...
Bird and Cronin, Inc. is a leading manufacturer of Patient Footwear, Orthopedic Softgoods, and Specialty Patient Care Products. Our products are of the highest quality and available in the USA and In
...Splint provides effective long-term stabilization ...le radial and palmar stays immobilize wrist and th...caphoid and soft tissue injuries. D-ring contact c...ior fit and unparalleled comfort. Padding thicknes...
Medicine Products: